“We should not allow it to be believed that all scientific progress can be reduced to mechanisms, machines, gearings, even though such machinery also has its beauty. Neither do I believe that the spirit of adventure runs any risk of disappearing in our world.”
— MARIE CURIE

LIFE SCIENCES CONSULTING SERVICES
Owned and operated in the US, Clinical Research Strategies is a contract research organization and executive management consultancy for start-up and mid-size life sciences companies. Project-specific, fit-for-purpose, ad hoc consulting, and staffing your clinical trials is what we do best no matter where you are in your clinical development program.
PHARMACEUTICAL COMPANIES
Protect your proprietary information while complying with transparency regs
International public disclosure regulations require that trial documentation be published in the public domain upon market authorization. Ensuring that your drug dossier is sufficiently redacted to protect your proprietary information is a complex and tedious task.
Clinical Research Strategies can alleviate the burden of redacting your clinical study reports, protocols, and similar documents. Our experts understand what is considered proprietary and can effectively ensure that your information is adequately protected.
WANT TO LEARN MORE?
Contact us today for a quote or capabilities presentation.
“Our mission is to improve your business’ performance and provide a successful clinical research development plan and strategy.”
We are with our clients for the long haul — the ups and downs — supported by resilience and pragmatism.
TOGETHER, WE CAN TRANSFORM THE CLINICAL DEVELOPMENT AND REGULATORY STRATEGY OF YOUR MEDICAL PRODUCT.

WHAT CRS CLIENTS ARE SAYING
Let the CRS team help you manage and overcome complicated trial operations and burdensome regulatory pathways.
Contact us today to arrange a no-obligation phone consultation.

CONTACT US TODAY!
THE LATEST FROM CLINICAL RESEARCH STRATEGIES
CRS Welcomes Olivia Moore as Our Newest Intern!
CRS has an Undergraduate Internship Affiliation Agreement with Penn State to provide students with a potential career trajectory opportunity which enhances their educational and career-oriented goals and experiences. The Special Topics course focuses on the practice of clinical research as a cornerstone to academic medicine and research, using novel approaches to treat disease while forging new best practices in clinical care. Together with the opportunity for internships, this course is a keystone part of Penn State’s Clinical Research Program.
CRS welcomes our first intern from Penn State, Olivia Moore, under this exciting program. Olivia is a senior at Penn State Greater Allegheny, majoring in biobehavioral health. Her career goal is to be involved in clinical research. While at CRS, she will have the opportunity to learn what clinical trial management involves, and a little about the associated regulatory requirements.
Please join the entire CRS team as we welcome Olivia!
EVENTS & MEDIA

UPCOMING EVENT
Inaugural Government Biotechnology Innovation Summit
September 27-28, 2023, The Sunset Room, National Harbor, MD
CRS Clinical and Regulatory Affairs Scientist, Dr. Haley Fuller, will be presenting “Translating Biotech from Concept to Clinic” discussing the strategies that CRS offers early- to mid-stage life science companies for traversing the clinical, regulatory, and quality landscape, while highlighting a few DoD- and DARPA-funded programs that CRS has helped strategize a path towards regulatory approval.
RESOURCES

Value-Based Healthcare in the United States
Alyssa Harris, MS – Clinical and Regulatory Affairs Project Lead II, Clinical Research Strategies
Jennifer Le, Pharm.D. – Clinical and Regulatory Affairs Project Lead, Clinical Research Strategies
CRS IN THE NEWS

CRS Ranks #34 in the 2023 Pittsburgh Business Times List of Life Sciences / Medical Device Companies
The region’s biotech ecosystem remains strong in Pittsburgh — fueled by the presence of UPMC, Highmark/Allegheny Health Network and fed by the University of Pittsburgh, Carnegie Mellon University, Duquesne University and other regional institutions — as is evidenced by the companies on the List of Life Sciences and Medical Device Firms in the Pittsburgh region.